RE-BVS – Piemonte Repository

Sfoglia per AUTORE
KATSAROS D
Collezione AOU Città della Salute di Torino

Items : 8

Validation of Androgen Receptor loss as a risk factor for the development of brain metastases from ovarian cancers. in Journal of ovarian research / J Ovarian Res. 2020 May 4;13(1):53. doi: 10.1186/s13048-020-00655-2.

2020
ASL VCO
AOU Città della Salute di Torino

Genta S; Tuninetti V; Giannone G; Ghisoni E; Maggiorotto F; Katsaros D; Sapino A; Borella F; Aglietta M; Senetta R; Fonte M; Scotto G; Gambino A; Goia M; Mittica G; Eusebi C; Momi M; Cassoni P; Valabrega G;

PIK3R1(W624R) Is an Actionable Mutation in High Grade Serous Ovarian Carcinoma. in Cells / Cells. 2020 Feb 14;9(2):442. doi: 10.3390/cells9020442.

2020
AOU Città della Salute di Torino

D'Ambrosio C; Erriquez J; Arigoni M; Capellero S; Mittica G; Ghisoni E; Borella F; Katsaros D; Privitera S; Ribotta M; Maldi E; Di Nardo G; Berrino E; Venesio T; Ponzone R; Vaira M; Hall D; Jimenez-Linan M; Paterson AL; Calogero RA; Brenton JD; Valabrega G; Di Renzo MF; Olivero M;

Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial. in The Lancet. Oncology / Lancet Oncol. 2019 Sep;20(9):1273-1285. doi: 10.1016/S1470-2045(19)30395-X. Epub 2019 Jul 22.

2019
AOU Città della Salute di Torino

de Boer SM; Powell ME; Mileshkin L; Katsaros D; Bessette P; Haie-Meder C; Ottevanger PB; Ledermann JA; Khaw P; D'Amico R; Fyles A; Baron MH; Jürgenliemk-Schulz IM; Kitchener HC; Nijman HW; Wilson G; Brooks S; Gribaudo S; Provencher D; Hanzen C; Kruitwagen RF; Smit VTHBM; Singh N; Do V; Lissoni A; Nout RA; Feeney A; Verhoeven-Adema KW; Putter H; et alii...

A predictive score for optimal cytoreduction at interval debulking surgery in epithelial ovarian cancer: a two- centers experience. in Journal of ovarian research / J Ovarian Res. 2018 May 30;11(1):42. doi: 10.1186/s13048-018-0415-y.

2018
AOU Città della Salute di Torino

Ghisoni E; Katsaros D; Maggiorotto F; Aglietta M; Vaira M; De Simone M; Mittica G; Giannone G; Robella M; Genta S; Lucchino F; Marocco F; Borella F; Valabrega G; Ponzone R;

MicroRNA let-7a modifies the effect of self-renewal gene HIWI on patient survival of epithelial ovarian cancer. in Molecular carcinogenesis / Mol Carcinog. 2016 Apr;55(4):357-65. doi: 10.1002/mc.22285. Epub 2015 Jan 28.

2016
AO Ordine Mauriziano
AOU Città della Salute di Torino

Yu H; Biglia N; Risch HA; Canuto EM; Katsaros D; Lu L;

LIN-28B/let-7a/IGF-II axis molecular subtypes are associated with epithelial ovarian cancer prognosis. in Gynecologic oncology / Gynecol Oncol. 2016 Apr;141(1):121-7. doi: 10.1016/j.ygyno.2015.12.035. Epub 2016 Jan 2.

2016
AO Ordine Mauriziano
AOU Città della Salute di Torino

Risch HA; Biglia N; Canuto EM; Katsaros D; Lu L; Yu H;

Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial. in The Lancet. Oncology / Lancet Oncol. 2014 Apr;15(4):396-405. doi: 10.1016/S1470-2045(14)70049-X. Epub 2014 Feb 28.

2014
AOU Città della Salute di Torino

Pignata S; Scambia G; Katsaros D; Gallo C; Pujade-Lauraine E; De Placido S; Bologna A; Weber B; Raspagliesi F; Panici PB; Cormio G; Sorio R; Cavazzini MG; Ferrandina G; Breda E; Murgia V; Sacco C; Cinieri S; Salutari V; Ricci C; Pisano C; Greggi S; Lauria R; Lorusso D; Marchetti C; Selvaggi L; Signoriello S; Piccirillo MC; Di Maio M; et alii...

Expression and clinical significance of the autophagy proteins BECLIN 1 and LC3 in ovarian cancer. in BioMed research international / Biomed Res Int. 2014;2014:462658. doi: 10.1155/2014/462658. Epub 2014 Jul 17.

2014
AOU Città della Salute di Torino

Valente G; Morani F; Nicotra G; Fusco N; Peracchio C; Titone R; Alabiso O; Arisio R; Katsaros D; Benedetto C; Isidoro C;